Alert!
Physicians
Back to Results


Bradley Hughes, MD
501.279.9393
Specialty
- Cardiology, Cardiology: Interventional Cardiology, Cardiology: Nuclear Cardiology
Medical School
University of Arkansas for Medical Sciences
Residency
University of Arkansas for Medical Sciences
Board Certifications
American Board of Internal Medicine / Cardiovascular Disease
Fellowship
University of Arkansas for Medical Sciences
Bio
Research:
- IMPROVE-IT: A multi-center, double-blind, randomized study to establish the clinical benefit and safety of vytorin (ezetimibe/simvastatin tablet) vs. simvastatin monotherapy in high-risk subjects presenting with acute coronary syndrome (IMProved Reduction of Outcomes: Vytorin Efficacy International Trial). On-going, active involvement in recruitment for this study.
Professional Societies/Memberships:
- Arkansas Medical Society
- American College of Physicians
- American College of Cardiology